Drug intelligence / Profile preview

PinnoThin TAG

Development stage: Unknown
Lead developer: Lipid Nutrition
Administration: Oral

Overview

PinnoThin TAG is a dietary supplement derived from Korean pine nut oil (*Pinus koraiensis*), specifically processed to contain high levels of triacylglycerols. It is primarily marketed for weight management and appetite suppression. The active component, pinolenic acid, is believed to stimulate the release of satiety hormones, including cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1), from the gastrointestinal tract. Clinical studies, such as NCT01034605, have investigated its effects on energy intake and satiety, though results have been mixed regarding its efficacy at standard dosages.

Brand names: PinnoThinPinnoThin TAG
Other names: Korean pine nut oilPinus koraiensis oilpine nut triacylglycerols

Targets

CCKAR (Cholecystokinin A receptor)GLP-1 (Glucagon-like peptide-1)

Beyond the preview

Go deeper on PinnoThin TAG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PinnoThin TAG.

Explore the full profile